Literatur
Ni Y, Shi G, Wan H. Use of cardioselective beta-blockers in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized, placebo-controlled, blinded trials. J Int Med Res. 2012;40:2051–65.
Worth H. Beta-Blocker bei Asthma und COPD - ein therapeutisches Dilemma? Pneumologie 2001;55:53–6.
Packer M, Bristiw MB, Roecker EB et al.: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996;334:1349–55.
Literatur
Kubota Y, Asai K, Furuse E et al. Impact of Betablocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2015;10:515–23.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Zeeuw, J. Ein Betablocker bei Herzschwäche plus COPD ist gut — aber nicht jeder!. Pneumo News 7, 15–16 (2015). https://doi.org/10.1007/s15033-015-0217-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15033-015-0217-5